Diagnosis, staging, and monitoring of cutaneous T-cell lymphoma

Dermatologic Therapy

Volumn 16, Issue 4, 2003, Pages 269-275

  Wood, Gary S ^a   Greenberg, H L ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Cutaneous T cell lymphoma; Immunogenotyping; Immunophenotyping; Mycosis fungoides; Polymerase chain reaction; S zary syndrome

Indexed keywords

BLOOD CYTOLOGY; CANCER CLASSIFICATION; CANCER STAGING; CLINICAL FEATURE; CUTANEOUS T CELL LYMPHOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; GENOTYPE; HISTOPATHOLOGY; HUMAN; IMMUNOPHENOTYPING; MYCOSIS FUNGOIDES; OBSERVER VARIATION; PATIENT MONITORING; PROGNOSIS; REPRODUCIBILITY; REVIEW; SERODIAGNOSIS; SEZARY SYNDROME; TUMOR DIAGNOSIS;

BIOPSY, NEEDLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MONITORING, PHYSIOLOGIC; MYCOSIS FUNGOIDES; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; SEZARY SYNDROME; SKIN NEOPLASMS;

EID: 0346099379     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1396-0296.2003.01637.x     Document Type: Review

References (38)

1. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994: 84: 1361-1392.
2. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997: 90: 354-371.
3. Jaffe E, Harris N, Stein H, Vardiman J, eds. WHO Classification of Tumors: Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
4. Wood GS. The benign and malignant cutaneous lymphoproliferative disorders including mycosis fungoides. In: Knowles DM, ed. Neoplastic Hematopathology, 2nd edn. Baltimore, MD: Williams & Wilkins, 2001: 1183-1233.
5. Vonderheid EC, Bernengo MG, Burg G, et al. ISCL update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002: 46: 95-106.
6. Everett MA. Early diagnosis of mycosis fungoides: vacuolar interface dermatitis. J Cutan Pathol 1985: 12: 271-278.
7. Jones RE, et al. Questions to the editorial board and other authorities. Am J Dermatopathol 1986: 8: 534-545.
8. Nickoloff BJ. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides. Am J Dermatopathol 1988: 10: 469-477.
9. King-Ismael D, Ackerman AB. Guttate parapsoriasis/digitate dermatosis (small plaque parapsoriasis) is mycosis fungoides. Am J Dermatopathol 1992: 14: 518-530; discussion 531-315.
10. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/ Sezary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol 1994: 18: 645-667.
11. Smoller BR, Bishop K, Glusac E, Kim YH, Hendrickson M. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol 1995: 19: 1423-1430.
12. Burg G, Dummer R, Nestle FO, Doebbeling U, Haeffner A. Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol 1996: 132: 567-572.
13. Guitart J, Hurt MA. Pleomorphic T-cell infiltrate associated with molluscum contagiosum. Am J Dermatopathol 1999: 21: 178-180.
14. Santucci M, Biggeri A, Feller AC, Massi D, Burg G. Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma Study Group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol 2000: 24: 40-50.
15. Santucci M, Biggeri A, Feller AC, Burg G. Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol 2000: 136: 497-502.
16. King LE, Jr. Erythroderma. Who, where, when, why, and how... Arch Dermatol 1994: 130: 1545-1547.
17. Weinberg JM, Jaworsky C, Benoit BM, Telegan B, Rook AH, Lessin SR. The clonal nature of circulating Sezary cells. Blood 1995: 86: 4257-4262.
18. Wood GS, Abel EA, Hoppe RT, Warnke RA. Leu-8 and Leu-9 antigen phenotypes: immunologic criteria for the distinction of mycosis fungoides from cutaneous inflammation. J Am Acad Dermatol 1986: 14: 1006-1013.
19. Rappl G, Muche JM, Abken H, et al. CD4(+) CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sezary syndrome. J Am Acad Dermatol 2001: 44: 456-461.
20. Bergman R, Faclieru D, Sahar D, et al. Immunophenotyping and T-cell receptor gamma gene rearrangement analysis as an adjunct to the histopathologic diagnosis of mycosis fungoides. J Am Acad Dermatol 1998: 39: 554-559.
21. Bernengo MG, Novelli M, Quaglino P, et al. The relevance of the CD4+ CD26- subset in the identification of circulating Sezary cells. Br J Dermatol 2001: 144: 125-135.
22. Scala E, Narducci MG, Amerio P, et al. T cell receptor-Vbeta analysis identifies a dominant CD60+ CD26- CD49d- T cell clone in the peripheral blood of Sezary syndrome patients. J Invest Dermatol 2002: 119: 193-196.
23. Ormsby A, Bergfeld WF, Tubbs RR, Hsi ED. Evaluation of a new paraffin-reactive CD7 T-cell deletion marker and a polymerase chain reaction-based T-cell receptor gene rearrangement assay: implications for diagnosis of mycosis fungoides in community clinical practice. J Am Acad Dermatol 2001: 45: 405-413.
24. Veelken H, Sklar JL, Wood GS. Detection of low-level tumor cells in allergic contact dermatitis induced by mechlorethamine in patients with mycosis fungoides. J Invest Dermatol 1996: 106: 685-688.
25. Wood GS, Haeffner A, Dummer R, Crooks CF. Molecular biology techniques for the diagnosis of cutaneous T-cell lymphoma. Dermatol Clin 1994: 12: 231-241.
26. Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T-cell receptor γ gene rearrangements in early mycosis fungoides/Sézary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol 1994: 103: 34-41.
27. Veelken H, Wood GS, Sklar J. Molecular staging of cutaneous T-cell lymphoma: evidence for systemic involvement in early disease. J Invest Dermatol 1995: 104: 889-894.
28. Wood GS, Uluer AZ. Polymerase chain reaction/denaturing gradient gel electrophoresis (PCR/DGGE): sensitivity, band pattern analysis and methodologic optimization. Am J Dermatopathol 1999: 21: 547-551.
29. Siddiqui J, Hardman DL, Misra M, Wood GS. Clonal dermatitis: a potential precursor of CTCL with varied clinical manifestations. J Invest Dermatol 1997: 108: 584.
30. Bunn PA, Lamberg SI. Report of the committee on staging and classification of cutaneous T-cell lymphomas. Cancer Treat Rep, 1979: 63: 725-728.
31. Weiss LM, Wood GS, Warnke RA. Immunophenotypic differences between dermatopathic lymphadenopathy and lymph node involvement in mycosis fungoides. Am J Pathol 1985: 120: 179-185.
32. Kern DE, Kidd PG, Moe R, Hanke D, Olerud JE. Analysis of T-cell receptor gene rearrangement in lymph nodes of patients with mycosis fungoides. Prognostic implications. Arch Dermatol 1998: 134: 158-164.
33. Fraser-Andrews EA, Woolford AJ, Russell-Jones R, Seed PT, Whittaker SJ. Detection of a peripheral blood T cell clone is an independent prognostic marker in mycosis fungoides. J Invest Dermatol 2000: 114: 117-121.
34. Muche JM, Lukowsky A, Ahnhudt C, Gellrich S, Sterry W. Peripheral blood T cell clonality in mycosis fungoides - an independent prognostic marker? J Invest Dermatol 2000: 115: 504-505.
35. Delfau-Larue MH, Dalac S, Lepage E, et al. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides. Blood 1998: 92: 3376-3380.
36. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J Exp Med 1994: 179: 609-618.
37. Moss P, Gillespie G, Frodsham P, Bell J, Reyburn H. Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia. Blood: 87: 3297-3306.
38. Pujol RM, Gallardo F, Llistosella E, et al. Invisible mycosis fungoides: a diagnostic challenge. J Am Acad Dermatol 2002: 47 (2 Suppl): S168-S171.